Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: in vitro and in silico studies

Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: in vitro and in silico studies

Abstract The parent 2-(4-benzyl-1-oxophthalazin-2(1H)-yl)-acetohydrazide (4) has twenty-nine compounds. The starting material for their corresponding mono, dipeptides and reactions with active methylene compounds were produced by chemoselective N-alkylation of 4-Benzyl-2H-phthalazin-1-one (2) with e...

Full description

Bibliographic Details
Main Authors:	Sara M. Emam, Samir M. El Rayes, Ibrahim A. I. Ali, Hamdy A. Soliman, Mohamed S. Nafie
Format:	Article
Language:	English
Published:	BMC 2023-07-01
Series:	BMC Chemistry
Subjects:	Phthalazine-based Selective anti-breast EGFR-mediated Apoptosis
Online Access:	https://doi.org/10.1186/s13065-023-00995-2

Similar Items

Phthalazine based hydrazone as potent radical scavenger: Synthesis, spectral characterization, single crystal X-ray diffraction, DFT studies, molecular docking, ADME, antioxidant and antimicrobial activity of (E)-1-(2-substitutedbenzylidene)phthalazine derivatives
by: Surya Uthrapathy, et al.
Published: (2025-01-01)

Synthesis of 1H-pyrazolo[1,2-b]phthalazine-5, 10-dione derivatives using Hercynite magnetic nanocatalyst
by: Zahra Paknejadi, et al.
Published: (2024-06-01)

Dinuclear silver(I) complexes with phthalazine: DNA/BSA binding and in vivo toxicity study
by: Ašanin Darko P., et al.
Published: (2023-01-01)

Dichloro{4-(4-chlorophenoxy)phthalazin-1-yl} methylphosphonic dichloride
by: Dyhia Amrane, et al.
Published: (2022-09-01)

Synthesis, Structure and Biological Activity of Novel 4,5-dihydro-1<i>H</i>-imidazol-2-yl-phthalazine Derivatives and Their Copper(II) Complexes
by: Łukasz Balewski, et al.
Published: (2022-11-01)

Structural Identification between Phthalazine-1,4-Diones and <i>N</i>-Aminophthalimides via Vilsmeier Reaction: Nitrogen Cyclization and Tautomerization Study
by: Cheng-Yen Chung, et al.
Published: (2021-05-01)

Marine-derived EGFR inhibitors: novel compounds targeting breast cancer growth and drug resistance
by: Qi Li, et al.
Published: (2024-05-01)

Cell cycle arrest and apoptotic studies of Terminalia chebula against MCF-7 breast cancer cell line: an in vitro and in silico approach
by: Pruthvish Reddy, et al.
Published: (2023-08-01)

Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E
by: Fatma Fouad Hagar, et al.
Published: (2023-09-01)

Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity
by: Mai A. E. Mourad, et al.
Published: (2023-12-01)

Cantharidin induces apoptosis of human triple negative breast cancer cells through mir-607-mediated downregulation of EGFR
by: Tianfeng Yang, et al.
Published: (2023-09-01)

Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
by: Alshimaa A. Y. Ahmed, et al.
Published: (2025-01-01)

New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study
by: Mariam M. Fakhry, et al.
Published: (2023-11-01)

One-pot and facile synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-diones using nano-NiO under solvent-free conditions
by: بهروز ملکی, et al.
Published: (2016-09-01)

EGFR promotes the apoptosis of CD4+ T lymphocytes through TBK1/Glut1 induced Warburg effect in sepsis
by: Li Huang, et al.
Published: (2023-02-01)

Synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives in a reusable catalyst/solvent; 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP)
by: Farzaneh Mohamadpour
Published: (2024-01-01)

Polyfluorinated alcohol as a reusable media promoted catalyst-free green synthesis of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives
by: Farzaneh Mohamadpour
Published: (2024-01-01)

In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers
by: Fahad Alminderej, et al.
Published: (2023-07-01)

The Role of Hydrogen Bond Interactions in Crystal Formation of Pyrrolo-Azines Alcohols
by: Marcel Mirel Popa, et al.
Published: (2025-01-01)

EGFR trafficking: effect of dimerization, dynamics, and mutation
by: Destiny F. Schultz, et al.
Published: (2023-09-01)

Acacetin exerts antitumor effects on gastric cancer by targeting EGFR
by: Guangtao Zhang, et al.
Published: (2023-05-01)

Role of EtMIC4 EGF-like in regulating the apoptosis of Eimeria tenella host cells via the EGFR pathway
by: Xue-song Zhang, et al.
Published: (2022-10-01)

Synthesis of some new 4-(2,4-dimethyl-phenyl)-2H-phthalazinone derivatives
by: Mamdouh A. Taha, et al.
Published: (2021-12-01)

Montmorillonite K-10 Supported 11-molybdo-1-vanadophosphoric Acid (H4PMo11V1O40/K-10) Catalysts for Environmentally Benign Synthesis of 2H-indazolo[2,1-b]phthalazine-triones Under Solvent-free Condition
by: Laxmikant D. Chavan, et al.
Published: (2017-10-01)

First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations
by: Tia Cheunkarndee, BA, et al.
Published: (2024-06-01)

In silico and in vitro evaluation of novel carbothioamide-based and heterocyclic derivatives of 4-(tert-butyl)-3-methoxybenzoic acid as EGFR tyrosine kinase allosteric site inhibitors
by: Imad M. Al-Rubaye, et al.
Published: (2024-01-01)

Comprehensive evaluation of antibacterial and anticancer activities from indole butanoic acid
by: Azhar H. Ali, et al.
Published: (2025-03-01)

Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation
by: Olivia A. Sagan, et al.
Published: (2023-05-01)

Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
by: Mohamed A. Mahmoud, et al.
Published: (2024-12-01)

Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer
by: Zhen Chen, et al.
Published: (2024-09-01)

Chemical Constituent Profiling of <i>Phyllostachys heterocycla</i> var. Pubescens with Selective Cytotoxic Polar Fraction through EGFR Inhibition in HepG2 Cells
by: Reda F. A. Abdelhameed, et al.
Published: (2021-02-01)

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors
by: Yongkang Bai, et al.
Published: (2023-04-01)

Design, Synthesis, and Anticancer Evaluation of Fused 1,2-diazine Derivatives
by: Antoci Vasilichia, et al.
Published: (2019-08-01)

Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
by: Mostafa E. Salem, et al.
Published: (2023-06-01)

pSTAT3 transactivates EGFR in maintaining EGFR protein homeostasis and EGFR-TKI resistance
by: Ao Juan, et al.
Published: (2024-09-01)

Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study
by: Duangjai Todsaporn, et al.
Published: (2023-03-01)

BASP1 promotes high glucose‐induced endothelial apoptosis in diabetes via activation of EGFR signaling
by: Fengnan Sun, et al.
Published: (2023-04-01)

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy
by: Zhulin Wang, et al.
Published: (2024-03-01)

Coordinated ASBT and EGFR Mechanisms for Optimized Liraglutide Nanoformulation Absorption in the GI Tract
by: Kweon S, et al.
Published: (2024-03-01)

Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
by: Mariam M. Fakhry, et al.
Published: (2022-10-01)